This is to inform you under Regulation 30 and any other regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the Board of Directors of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of ANG Lifesciences India Ltd, at its meeting held on September 6, 2025, approved several routine corporate items. These include the appointment of M/s Shreya Sahu & Associates as Cost Auditor for FY 2025-26, approval of the Board's Report for FY 2024-25, and fixing the 19th Annual General Meeting on September 30, 2025 at 11:30 AM via video conferencing. The Board also appointed M/s Anil Negi & Company as Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30) and as Scrutinizer for the AGM. Book closure dates were set from September 24 to September 30, 2025 with a cut-off date of September 23, 2025 for determining voting eligibility. Additionally, the Board approved a revision in the remuneration of Mrs. Saruchi Gupta, Whole-time Director, subject to shareholder approval at the upcoming AGM.
These are largely procedural and routine corporate governance actions ahead of the AGM, with no major strategic shifts announced. The director remuneration revision may be marginal for shareholder returns, while the five-year auditor appointments provide continuity in compliance oversight.